1. A composition comprising a protein hydrolyzate, milk-based, obtained by treating a solution of the protein material to lactic osnovea) at least one trypsin-like endopeptidase derived from a microorganism, and b) at least one chymotrypsin-like endopeptidase derived from a microorganism for use as a medicament drug or as a composition with therapeutic or prophylactic effektom.2. The composition according to claim 1 for the stimulation of oral tolerance in infants or patients who need it, or to reduce the risk of allergies in infants or patients who need it, or to reduce the severity and frequency of allergy during infancy or later in life, in especially in infants or need it patsientov.3. A composition according to claim 1, wherein at least one trypsin-like endopeptidase derived from a strain of Fusarium, preferably Fusarium oxysporum, and has at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identical to the sequence designated as the SWISSPROT №P35049.4. A composition according to claim 1, wherein at least one trypsin-like endopeptidase derived from a strain Kutzneria, preferably Kutzneria albida, and has at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1.5. A composition according to claim 1, wherein at least one himotripsinop1. Композиция, содержащая белковый гидролизат на молочной основе, полученный путем обработки раствора белкового материала на молочной основеa) по меньшей мере одной трипсиноподобной эндопептидазой, полученной из микроорганизма, иb) по меньшей мере одной химотрипсиноподобной эндопептидазой, полученной из микроорганизма,для применения в качестве лекарственного средства или в качестве композиции с лечебным или профилактическим эффектом.2. Композиция по п.1 для стимуляции пероральной толерантности у грудных детей и
